Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (ACTRN12625001091493) titled 'The FERTILE Study: Evaluating ovarian toxicity outcomes following immunotherapy in patients with Triple-Negative Breast Cancer (TNBC)' on Oct. 8.
Study Type: Observational
Study Design:
Duration: Longitudinal
Selection: Defined population
Timing: Prospective
Primary Sponsor: Peter MacCallum Cancer Centre
Condition:
Breast cancer
Menopause
Fertility
Breast cancer
Menopause
Fertility
Cancer - Breast
Reproductive Health and Childbirth - Menstruation and menopause
Reproductive Health and Childbirth - Fertility including in vitro fertilisation
Intervention:
This is a prospective study aiming to describe w...